Royal Bank Of Canada Biocryst Pharmaceuticals Inc Transaction History

Royal Bank Of Canada

$479 Billion
Q4 2024

A detailed history of Royal Bank Of Canada transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, Royal Bank Of Canada holds 62,005 shares of BCRX stock, worth $561,145. This represents 0.0% of its overall portfolio holdings.

Number of Shares

62,005

Previous 66,556 6.84%

Holding current value

$561,145

Previous $505,000 7.72%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$7.03 - $8.43 $31,993 - $38,364	-4,551 Reduced 6.84%	62,005 $466,000
Q3 2024 Nov 14, 2024	SELL	$6.41 - $8.69 $65,805 - $89,211	-10,266 Reduced 13.36%	66,556 $505,000
Q2 2024 Aug 14, 2024	SELL	$4.13 - $6.79 $179,407 - $294,957	-43,440 Reduced 36.12%	76,822 $474,000
Q1 2024 Nov 05, 2024	BUY	$4.89 - $7.65 $212,421 - $332,316	43,440 Added 56.55%	120,262 $610,000
Q1 2024 May 15, 2024	BUY	$4.89 - $7.65 $32,953 - $51,553	6,739 Added 5.94%	120,262 $610,000
Q4 2023 Feb 14, 2024	BUY	$4.98 - $6.77 $278,292 - $378,321	55,882 Added 96.95%	113,523 $680,000
Q3 2023 Nov 14, 2023	BUY	$6.71 - $7.92 $89,893 - $106,104	13,397 Added 30.28%	57,641 $408,000
Q2 2023 Aug 14, 2023	SELL	$6.96 - $8.81 $194,184 - $245,799	-27,900 Reduced 38.67%	44,244 $311,000
Q1 2023 May 15, 2023	SELL	$7.94 - $11.84 $100,758 - $150,249	-12,690 Reduced 14.96%	72,144 $601,000
Q4 2022 Feb 14, 2023	BUY	$10.5 - $14.2 $610,312 - $825,375	58,125 Added 217.62%	84,834 $973,000
Q3 2022 Nov 14, 2022	SELL	$10.79 - $14.81 $591,755 - $812,224	-54,843 Reduced 67.25%	26,709 $337,000
Q2 2022 Aug 15, 2022	BUY	$7.89 - $17.88 $236,486 - $535,917	29,973 Added 58.11%	81,552 $863,000
Q1 2022 May 16, 2022	SELL	$11.56 - $19.76 $316,455 - $540,930	-27,375 Reduced 34.67%	51,579 $839,000
Q4 2021 Feb 14, 2022	BUY	$11.18 - $15.46 $238,379 - $329,638	21,322 Added 37.0%	78,954 $1.09 Million
Q3 2021 Nov 15, 2021	BUY	$14.21 - $17.65 $313,145 - $388,953	22,037 Added 61.91%	57,632 $829,000
Q2 2021 Aug 16, 2021	BUY	$9.5 - $17.24 $338,152 - $613,657	35,595 New	35,595 $563,000

Others Institutions Holding BCRX

# of Institutions

278

Shares Held

167M

Call Options Held

802K

Put Options Held

989K

View Full List

About BIOCRYST PHARMACEUTICALS INC

Ticker BCRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,944,992
Market Cap $1.68B
Description
BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...

More about BCRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.

Account

Royal Bank Of Canada Biocryst Pharmaceuticals Inc Transaction History